Gastric Cancer

This page contains recent news articles, when available, and an overview of Gastric Cancer but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Gastric Cancer

CytRx: Technical Breakout Imminent  -  23 Nov 2009
Seeking Alpha (blog)...in a broad array of cancer indications, and are hopeful that this carefully-designed study will bring hope to the sufferers of advanced gastric cancer. ...

Failed cancer treatment doubly painful for widow  -  ‎Nov 16, 2009‎
Chicago TribuneShe said neither she nor her late husband were told Avastin was not a covered treatment for gastric cancer. "This was a total shock to me," she said. ...

New gastric cancer drug approved  -  ‎Nov 20, 2009‎
Pharmacy EuropeAdvanced gastric cancer medication S-1 was validated for use with cisplatin for Taiho Pharmaceutical Company, Ltd. Gastric cancer affects more than twice as ...

Singapore A*STAR Invests $36 Million In Medical Technology Industry  -  ‎Nov 22, 2009‎
Gov MonitorThe on-going systemic study of screening for gastric cancer under the Gastric Cancer TCR Flagship Programme has recruited more than 2400 high-risk ...

CytRx to Initiate Phase 2 Clinical Trial with INNO-206 in Patients with ...  -  ‎Nov 18, 2009‎
WELT ONLINEFifty patients with gastric cancer who have failed other treatments, including surgery and chemotherapy with drugs other than doxorubicin (anthracyclines), ...

Cancer: New Explanation Of 'Asian Paradox'  -  ‎Oct 28, 2009‎
Science Daily (press release)The difference in the pattern of H. pylori-associated gastritis may explain the difference in the incidence of gastric cancer between Indonesia and Japan. ...

Marketing Authorisation Application for S-1 Validated by European Medicines Agency  -  ‎Nov 22, 2009‎
PR-CANADA.net (press release)S-1 was designated as an orphan medicinal product for the treatment of gastric cancer by the EMEA on 20 December 2007. "Gastric cancer is an area of ...

Driven by the Launch of Targeted Agents, the Gastric Cancer Drug Market Will ...  -  ‎Nov 4, 2009‎
ReutersThe new Pharmacor report entitled Gastric Cancer finds that, in the first-line setting, market growth will be driven by the launches of Roche/Chugai's ...

Emerging Therapies in Pancreatic Cancer Show Promise  -  ‎Nov 17, 2009‎
PhysOrg.comTumor suppressor microRNA miR-34 inhibits human pancreatic and gastric cancer stem cells Treatment with miR-34, a microRNA, significantly reduced pancreatic ...

African-Americans with colorectal cancer have poorer outcomes, lower survival ...  -  ‎Nov 12, 2009‎
EurekAlert (press release)Survival was similarly poor for pancreatic and gastric cancer patients regardless of race. In conducting a multivariate analysis, the research team found ...

Re-organisation of oesophago-gastric cancer care in England: progress and ...  -  ‎Nov 12, 2009‎
7thSpace Interactive (press release)Oesophago-gastric cancer services in England have been extensively reorganised since 2001 to deliver a centralised, specialist-led service. ...

Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090  -  ‎Nov 18, 2009‎
RTT News (press release)...gastrointestinal stromal tumors (GIST), prostate cancer, colon cancer, breast cancer, gastric cancer, pancreatic cancer, colon cancer, melanoma, ...

Response Genetics, Inc. Reports Third Quarter 2009 Financial Results Driven by ...  -  ‎Nov 16, 2009‎
RTT News (press release)We continue to be encouraged by our sales growth and outlook for ResponseDX(TM) diagnostic tests for lung, colon and gastric cancer. ...

European CHMP Formally Adopts Negative Opinion on Oncophage®  -  ‎Nov 20, 2009‎
WELT ONLINE...signals in multiple cancers, including melanoma, glioma, colorectal, pancreatic, renal cell carcinoma, gastric cancer and non-Hodgkins lymphoma. ...

UPDATE 3-EU panel blocks Merck KGaA's Erbitux in lung cancer  -  ‎Nov 19, 2009‎
路透中国The company is working on further uses of the drug in bowel cancer and against gastric cancer. Merck had been trying to persuade the CHMP to reconsider its ...

Major Advances in Clinical Cancer Research in 2009: A Report From ASCO  -  ‎Nov 17, 2009‎
MedscapeTrastuzumab improves survival in human epidermal growth-factor receptor 2 (HER2)-positive gastric cancer. The phase 3 ToGA study reports significantly ...

John Lynch Sr.  -  ‎Nov 19, 2009‎
NCAdvertiser.comJohn Gibbons Lynch Sr. of Cary, Ill., and Inverness, Fla., died on Tuesday, November 10, after a brief bout with gastric cancer. He was 87. ...

Health Matters : What is Gastric Cancer ?  -  ‎Nov 5, 2009‎
PR-Inside.com (Pressemitteilung)Excessive exposure of the stomach to these compounds can lead to damage of the stomach lining and possible gastric cancer formation. ...

Response Genetics Releases 3Q 2009 Financial Results  -  ‎Nov 17, 2009‎
Trading Markets (press release)We continue to be encouraged by our sales growth and outlook for ResponseDX diagnostic tests for lung, colon and gastric cancer. ...

AACR: Emerging Pancreatic Cancer Treatments Evaluated Cancer conference shows ...  -  ‎Nov 19, 2009‎
ModernMedicineIn other research, restoring the microRNA miR-34 in p53-mutant human pancreatic and gastric cancer cells inhibited cell growth and sensitized them to ...

Blake Sorry To See Pilot Pen Tournament Lose Sponsor  -  ‎Nov 17, 2009‎
Hartford CourantThomas was Blake's father, who died of gastric cancer in 2004. "I really don't know how to describe the feeling of gratitude that I get for those types of ...

In the Literature  -  ‎Nov 5, 2009‎
The Hospitalist OnlineTreating for H. Pylori Reduces the Risk for Developing Gastric Cancer in High-Risk Patients Clinical question: In patients with high-baseline incidence of ...

OTC: Genta Announces Third Quarter 2009 Financial Results and Restructuring to ...  -  ‎Nov 16, 2009‎
RTT News (press release)Dose-ranging study of a new once-weekly treatment schedule; -- Phase 2b trial in 2nd-line gastric cancer. Prior to initiating a Phase 3 trial, ...

Report Highlights Cancer Advances  -  ‎Nov 9, 2009‎
MedPage TodayA large Phase III clinical trial of patients with HER2-positive gastric cancer had a significant reduction in the risk of death when treated with ...

YM BioSciences Q1 Loss Widens - Update  -  ‎Nov 11, 2009‎
RTT News...the company plans more clinical trials, for recording significant clinical data including those of glioma, pediatric gliamo and gastric cancer. ...

ASCO Releases Annual Progress Report on Top Cancer Research Advances  -  ‎Nov 11, 2009‎
Media Newswire (press release)...which has been successful against breast tumors that overexpress the HER2 protein, was found to improve survival for HER2+ gastric cancer. ...

The Dr. Oz tv show recap, episode 42  -  ‎Nov 10, 2009‎
Examiner.comE. Coli, 300000 had it last year and ½ home kitchens in a study tested positive H. Plyori, if not treated, can end in gastric cancer Choreographer Stepp ...

EU panel blocks Merck KGaA's Erbitux in lung cancer  -  ‎Nov 19, 2009‎
Forbes...for use against cancer of the bowel and of the head and neck. The company is working on further uses of the drug in bowel cancer and against gastric cancer.

Genotypes of Patients With Helicobacter pylori Infection May be More ...  -  ‎Nov 10, 2009‎
DG NewsDr. Gunturu said that the researchers are working on a follow-up study to test the hypothesis, involving 86 gastric cancer patients in Germany and 56 ...

YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS  -  ‎Nov 12, 2009‎
PR Newswire (press release)...with advanced or recurrent gastric cancer refractory to 5-FU- containing regimens which is reportedly expected to complete recruitment in calendar 2009. ...

Patrys moves forward with ARC grant  -  ‎Nov 10, 2009‎
Australian Life Scientist...antibody that is being used to target solid tumours and metastases in a range of cancers, including melanoma, pancreatic cancer and gastric cancer. ...

Dyax Corp. Q3 2009 Earnings Call Transcript  -  ‎Oct 28, 2009‎
Seeking Alpha (blog)...to expand its VEGF receptor drug candidate called IMC-1121B, currently in Phase III for breast cancer into another Phase III study for gastric cancer. ...

Celera Licenses Lung Cancer Intellectual Property from Medical Therapies  -  ‎Oct 29, 2009‎
ReutersKumai H. Serum midkine concentrations and gastric cancer. Cancer Sci 2005 January;96(1):54-6. 2. Maeda S, et al. Clinical significance of midkine expression ...

Will genomics help prevent the next pandemic?  -  ‎Oct 28, 2009‎
Science Centric...and some identified only relatively recently, such as the bacterium Helicobacter pylori, which is associated with peptic ulcers and gastric cancer. ...

COMUNICADO: Solicitud de autorización de marketing para S-1 validada por la ...  -  ‎Nov 20, 2009‎
Europa PressChapter 13: Gastric Cancer. Cancer Management: A Multidisciplinary Approach, 10 Edición, 2007. John F. Kouten de JFK Communications para Taiho ...

La demande d'autorisation de mise sur le marché du S-1 est validée par l ...  -  ‎Nov 19, 2009‎
SYS-CON Media (press release)Multicenter Phase 3 Comparison of Cisplatin/S-1 (CS) with Cisplatin/ 5-FU (CF) as First-Line Therapy in Patients with Advanced Gastric Cancer (FLAGS). ...

Marktzulassungsantrag für S-1 von der Europäischen Arzneimittelagentur genehmigt  -  ‎Nov 20, 2009‎
SYS-CON Media (press release)Multicenter Phase 3 Comparison of Cisplatin/S-1 (CS) with Cisplatin/ 5-FU (CF) as First-Line Therapy in Patients with Advanced Gastric Cancer (FLAGS). ...

허셉틴·HER2 검사, 위암 진단·치료?? 효과  -  ‎Oct 30, 2009‎
KMA Times...오?연 서울?대 ?수(서울대병? 내과)는 최근 대한병리학회 학술대회 런천세미나?서 유방암 치료제로 사용하고 있는 로슈? 허셉틴? 위암(Gastric Cancer)환? ...



Background information on Gastric Cancer [When available]

In medicine, stomach cancer (also called gastric cancer) can develop in any part of the stomach and may spread throughout the stomach and to other organs. The cancer may grow along the stomach wall into the esophagus or small intestine.

It also may extend through the stomach wall and spread to nearby lymph nodes and to organs such as the liver, pancreas, and colon. Stomach cancer also may spread to distant organs, such as the lungs, the lymph nodes above the collar bone, and the ovaries.

When cancer spreads to another part of the body, the new tumor has the same kind of abnormal cells and the same name as the primary tumor. For example, if stomach cancer spreads to the liver, the cancer cells in the liver are stomach cancer cells and the disease is metastatic stomach cancer, not liver cancer.

A well known complication of stomach cancer is when it spreads to an ovary; the tumor in the ovary is called a Krukenberg tumor. This tumor, named for the doctor who first described it, is not a different disease; it is metastatic stomach cancer - the cancer cells in a Krukenberg tumor are stomach cancer cells, the same as the cancer cells in the primary tumor.

Search the web for more resources on Gastric Cancer



Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy